GLP-1 Family intermediate
GLP-1 Agonist Diabetes Remission
Potential for GLP-1 receptor agonists to achieve type 2 diabetes remission through beta cell preservation and weight loss.
By Encyclopeptide Editorial | 1 min read
GLP-1 remission type-2-diabetes beta-cell metabolic
Definition of Remission
- HbA1c <6.5% without glucose-lowering therapy for >=3 months
- Fasting glucose <100 mg/dL without medication
Clinical Evidence
Semaglutide (STEP Trials)
- Remission rate: 30-50% at 68 weeks
- Sustained remission: 20-30% at 2 years
Tirzepatide (SURPASS)
- Remission rate: 40-55% at 40 weeks
Mechanisms of Remission
- Beta cell preservation
- Weight loss reducing insulin resistance
- Improved insulin sensitivity
- Reduced glucotoxicity
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 Agonist Diabetes Remission |
| Category | GLP-1 Family |
References
- Encyclopeptide Database. “GLP-1 Agonist Diabetes Remission” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about GLP-1 Agonist Diabetes Remission with interactive quizzes on Wikipept.
Take a Quiz on Wikipept